SEC Form 4 · accession 0001209191-15-029857
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Guy Macdonald
Officer — President and Chief Executive · Director
Period of report
Mar 26, 2015
Accepted (ET)
Mar 27, 2015 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 26, 2015 | M | 20,000 | $0.87 | A | 70,537 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $0.87 | Mar 26, 2015 | M | 20,000 | A | — | Sep 10, 2019 | Common Stock | 20,000 | 89,323 | D |
Explanation of responses
- F1Fully vested.